%0 Journal Article
%T Characterization of zolbetuximab in pancreatic cancer models
%A Rita Mitnacht-Kraus
%A Stefan W£¿ll
%A Tomohiro Yamada
%A Ugur Sahin
%A £¿zlem T¨¹reci
%J Archive of "Oncoimmunology".
%D 2019
%R 10.1080/2162402X.2018.1523096
%K Claudin 18.2
%K zolbetuximab
%K IMAB362
%K monoclonal antibody
%K targeted therapy
%K pancreatic cancer
%K antibody-dependent cellular cytotoxicity
%K ADCC
%K complement-dependent cytotoxicity
%K immunotherapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287799/